USFDA concludes inspection of Indoco's Sterile facility (Plant II)
The US Food and Drug Administration (USFDA) conducted audit at Indoco's
sterile manufacturing facility in Verna, Goa (Plant II) from 27th May'19 to 4th June'19, issuing 4 observations (483s). These observations are procedural in nature, not pertaining to data integrity. The Company will submit its responses shortly.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 05 2019 | 11:57 AM IST